Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose thrombolysis, ultrasound-assisted thrombolysis, or heparin for intermediate-high-risk pulmonary embolism
2017-005075-91Phase 4Completed
- Sponsor
- Copenhagen University Hospital Rigshospitalet
- Start
- May 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of tissue-plasminogen activator, heparin in pulmonary embolism (PE), sponsored by Copenhagen University Hospital Rigshospitalet. Started May 2018; status: completed.
02
Drugs
tissue-plasminogen activatorheparin
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on 2017-005075-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005075-91.